e-SPACE Heart Failure 2021
Published: 07 December 2021
-
Views:
6479 -
Likes:
7
-
Views:
6479 -
Likes:
7
-
Up Next
-
1h 5m 20sPart 1 | Session 4 State of the art management of chronic HF
-
44m 49s
-
1h 5m 53sPart 1 | Session 6 Acute HF and the transition to ambulatory care
-
1h 4m 2sPart 1 | Session 7 Update on advanced HF, assist devices and heart transplantation
-
21m 56s
-
1h 6m 7sPart 1 | Session 9 Difficult problems in HF
-
1h 7m 48sPart 2 | Session 1 Co-morbidities in HF affecting QoL and hard outcomes (part 1)
-
45m 28s
-
1h 9m 18sPart 2 | Session 3 Co-morbidities in HF affecting QoL and hard outcomes (part 2)
-
1h 6mPart 2 | Session 4 Valvular heart disease in HF
-
42m 18s
-
1h 4m 1sPart 2 | Session 6 Real-world data, Covid-19 & biomarkers
-
1h 4m 13sPart 2 | Session 7 The new HF guidelines: diagnostic & treatment algorithms
-
44m 53s
-
1h 5m 26sPart 2 | Session 9 State of the art management of chronic HF
-
1h 7m 20sPart 3 | Session 1 Acute HF and the transition to ambulatory care
-
36m 34s
-
1h 5m 20sPart 3 | Session 3 Update on advanced HF, assist devices and heart transplantation
-
1h 4m 54sPart 3 | Session 4 Difficult problems in HF
-
45m 38s
-
1h 6m 4sPart 3 | Session 6 Co-morbidities in HF affecting QoL and hard outcomes (part 1)
-
52m 48sPart 3 | Session 7 Co-morbidities in HF affecting QoL and hard outcomes (part 2)
-
52m 48s
-
58m 45sPart 3 | Session 9 Valvular heart disease in HF
-
1h 3m 5sPart 1 | Session 1 Real-world data, Covid-19 & biomarkers Lars H Lund, James L Januzzi
Overview
e-SPACE Heart Failure 2021 was the second edition of the annual global online conference on heart failure. Brining together leading experts from across the globe, the sessions were designed to provide insight and best demonstrate how leading experts are implementing the new heart failure guidelines into clinical practice. Discover the latest information on diagnosis and evidence-based management strategies from across the globe.
Heart failure is a major public health problem facing millions of patients worldwide. It represents an ever-increasing burden for healthcare systems, patients and healthcare professionals. Care for heart failure patients requires constant education and up-to-date information. The health outcomes of heart failure patients depend upon the implementation of best care approaches and evidence-based management strategies. e-SPACE Heart Failure 2021 strives to share the latest scientific information with the global medical community.
These on-demand recordings of the live virtual event (8 – 10 October 2021) comprise:
- Expert opinion and discussions from +40 international heart failure experts
- +10 sessions covering the latest HF scientific information and education
- Meet the Expert sessions and Symposia
More from this programme
Part 1
DAY 1
Part 2
DAY 2
Part 3
DAY 3
Faculty Biographies
Justin Ezekowitz
Dr. Ezekowitz, an accomplished professional in the field of cardiology, serves as the co-director of the Canadian VIGOUR Centre at the University of Alberta. He has spearheaded the establishment of five new heart failure clinics across Alberta to enhance access to specialized services. Furthermore, he plays a pivotal role in co-chairing the heart failure care pathway initiative as part of Alberta Health Services Strategic Clinical Networks.
Dr. Ezekowitz's clinical focus centers on cardiology, with a primary emphasis on heart failure. He practices at the Mazankowski Alberta Heart Institute, where he contributes to the Heart Function Clinic.
In the realm of research, Dr. Ezekowitz dedicates his efforts to acute and chronic heart failure, particularly in individuals with heart "pump" issues or end-stage heart disease. He actively engages in numerous local and international clinical trials aimed at identifying novel treatments and care strategies for heart failure…
Marco Metra
Professor
Marco Metra is Full Professor of Cardiology and Director of the Institute of Cardiology of the Civil Hospital and University of Brescia, Italy, and Editor-in-Chief of the European Journal of Heart Failure and Senior Consulting Editor of the European Heart Journal.
Prof Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with heart failure. His research is focused on heart failure with, as main areas of interest, β-blocker therapy and, more recently, the assessment and treatment of the patients with acute heart failure.
He has co-chaired with Prof. Teerlink, San Francisco, CA, the phase IIB Pre-RELAX-AHF and the phase III RELAX-AHF randomized placebo controlled trials in patients with acute heart failure and is chairing the current RELAX-AHF-2 trial, which has as primary end-points the effects of serelaxin on the 180-days mortality and on in-hospital worsening heart…